InvestorsHub Logo
Followers 129
Posts 3809
Boards Moderated 0
Alias Born 07/12/2003

Re: None

Tuesday, 01/31/2023 12:45:30 PM

Tuesday, January 31, 2023 12:45:30 PM

Post# of 198710
Nasser Alhaj Ali, Ph.D.
Research Scientist


About
I am a research scientist with Enzolytics Inc, a drug development company that focuses on multiple therapies for infectious diseases. I am leading the development of vaccines in the areas of infectious disease and chronic medical disease to create effective therapeutic monoclonal antibodies. My project focus on designing and developing next-generation monoclonal antibodies (mAbs) that represent one of the fastest-growing classes of protein therapeutics.
I have demonstrated expertise in understanding of immune system, preparing and optimizing protocols, identifying and troubleshooting experimental issues, and determining appropriate solutions.
I am an articulate team player, proficient in evaluating and analyzing validation data, verifying the adequacy of data, organizing and managing documents/reports, organizing and arranging large-scale experiments.
I possess in-depth knowledge and working understanding of immunoassays and molecular assays in BSL1 and BSL2 environments.
I orchestrate strong communication, critical thinking, and exceptional lab skills. Capable of leading research projects within strict time and budget constraints.
While others take pride in meeting all standards set before them, my passion is for delivering service that goes beyond organizational expectations, creating a win-win scenario for everyone involved!" Please feel free to contact me at alhaj2001@aggienetwork.com with any thoughts, comments, or questions about my work. I'm always interested in making new professional acquaintances.

Postdoctoral Researcher
Enzolytics Immunotherapeutics
May 2021 - Present1 year 9 months

College Station, TX, United States

https://www.linkedin.com/in/nasser-alhaj-ali-ph-d-90b07658
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News